Lunai Bioworks Inc (LNAI)

$0.30 -0.02 (-5.41%)
Market Cap 7.83M
Revenue (ttm) 0.00
Net Income (ttm) -178.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 618,931
Avg Vol 26,674,518
Day's Range N/A - N/A
Shares Out 24.19M
Stochastic %K 37%
Beta 0.34
Analysts Strong Buy
Price Target N/A

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 918 1980
Address:
2080 Century Park East, Suite 906, Los Angeles, United States
TCLutz
TCLutz May. 13 at 4:42 PM
$EZGO $HAO $KRKR $LNAI $POM Gamble…
0 · Reply
only1mc
only1mc May. 13 at 4:41 PM
$WOK 144 million traded. and climbing.. Im sure hedges don't want a lawsuit like $LNAI . .. no more shares left. 🚀 squeeze em
1 · Reply
MACnTEEZ
MACnTEEZ May. 13 at 3:43 PM
$LNAI gapper soon
0 · Reply
matthewboyntonbeach
matthewboyntonbeach May. 13 at 2:35 PM
$LNAI Blackrock owns 127,314 shares, if they start loading up more shares we going wayyyyy higher
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 13 at 1:19 PM
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research $OTLC $AMGN $JNJ $ABBV $LNAI https://ibn.fm/v9RPJ
0 · Reply
matthewboyntonbeach
matthewboyntonbeach May. 13 at 3:19 AM
$LNAI do something stupid tomorrow please, like open above $1.50
1 · Reply
MACnTEEZ
MACnTEEZ May. 12 at 11:58 PM
$LNAI people didnt digest or see the news, this will gap soon, ill give it few days!
0 · Reply
TCLutz
TCLutz May. 12 at 9:05 PM
$HAO <— $AIXI $LNAI $NVDA $SPY THE QUEEN HAS SPOKEN!! 🫡💪
0 · Reply
TCLutz
TCLutz May. 12 at 9:00 PM
$HAO <— $AIXI $LNAI $NVDA $SPY LOWEST PRICED + EXTREMELY OVERSOLD AI PLAY ON THE ENTIRE MARKET Offering closes today. Raised a measly $6.5m… Should rebound HARD to .25 or better!! 💪🫡🔥
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 12 at 7:21 PM
InvestorNewsBreaks – $LNAI Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit https://ibn.fm/xlRH8
0 · Reply
Latest News on LNAI
Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe' ‘Naked' Short-Sellers of Lunai Common Stock

May 12, 2026, 12:12 AM EDT - 1 day ago

Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe' ‘Naked' Short-Sellers of Lunai Common Stock

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

May 4, 2026, 9:35 AM EDT - 9 days ago

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Apr 15, 2026, 9:10 AM EDT - 4 weeks ago

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Apr 7, 2026, 9:05 AM EDT - 5 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Lunai Bioworks acquires BBB delivery platform in Alzheimer’s for $20M

2026-03-26T12:55:26.000Z - 6 weeks ago

Lunai Bioworks acquires BBB delivery platform in Alzheimer’s for $20M

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

Mar 26, 2026, 8:50 AM EDT - 6 weeks ago

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

Lunai Bioworks announces formation of Pathfinder Consortium

2026-03-19T14:10:31.000Z - 7 weeks ago

Lunai Bioworks announces formation of Pathfinder Consortium

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Mar 19, 2026, 9:57 AM EDT - 7 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Why Is Lunai Bioworks Stock (LNAI) Rallying Today?

2026-03-17T12:29:40.000Z - 2 months ago

Why Is Lunai Bioworks Stock (LNAI) Rallying Today?

Lunai Bioworks granted U.S. patent for AI drug discovery system

2026-02-19T13:47:50.000Z - 2 months ago

Lunai Bioworks granted U.S. patent for AI drug discovery system

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Feb 19, 2026, 8:30 AM EST - 2 months ago

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

Feb 13, 2026, 8:31 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

Lunai Bioworks CEO says established three ‘scalable revenue generating engines’

2026-02-09T16:25:07.000Z - 3 months ago

Lunai Bioworks CEO says established three ‘scalable revenue generating engines’

Lunai Bioworks announces oncology collaboration with a clinical-stage partner

2026-02-09T14:20:50.000Z - 3 months ago

Lunai Bioworks announces oncology collaboration with a clinical-stage partner

Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

Feb 9, 2026, 9:15 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Jan 27, 2026, 10:36 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Lunai Bioworks expands AI program into commercial AUD drug discovery

2026-01-26T14:35:53.000Z - 3 months ago

Lunai Bioworks expands AI program into commercial AUD drug discovery

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

Jan 26, 2026, 9:30 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

Dec 18, 2025, 9:00 AM EST - 5 months ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

Dec 9, 2025, 7:45 AM EST - 5 months ago

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license

2025-11-25T12:55:12.000Z - 6 months ago

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Nov 25, 2025, 7:45 AM EST - 6 months ago

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Lunai Bioworks announces regression of tumors with immune cell therapy

2025-11-05T14:34:03.000Z - 6 months ago

Lunai Bioworks announces regression of tumors with immune cell therapy

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Nov 5, 2025, 9:22 AM EST - 6 months ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Lunai Bioworks announces early results from AI-based platform

2025-10-30T13:41:27.000Z - 6 months ago

Lunai Bioworks announces early results from AI-based platform

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Oct 30, 2025, 9:32 AM EDT - 6 months ago

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

Oct 16, 2025, 9:45 AM EDT - 7 months ago

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

Lunai Bioworks regains compliance with Nasdaq minimum bid price rule

2025-10-16T13:30:37.000Z - 7 months ago

Lunai Bioworks regains compliance with Nasdaq minimum bid price rule

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 16, 2025, 9:15 AM EDT - 7 months ago

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Oct 6, 2025, 9:15 AM EDT - 7 months ago

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 30, 2025, 9:15 AM EDT - 8 months ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 25, 2025, 8:30 AM EDT - 8 months ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 24, 2025, 4:50 PM EDT - 8 months ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 11, 2025, 7:00 AM EDT - 8 months ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 9, 2025, 8:47 AM EDT - 8 months ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 8, 2025, 8:50 AM EDT - 8 months ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Lunai Bioworks Inc. Retains American Defense International

Sep 4, 2025, 10:05 AM EDT - 8 months ago

Lunai Bioworks Inc. Retains American Defense International

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 27, 2025, 9:45 AM EDT - 9 months ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Aug 8, 2025, 10:45 AM EDT - 9 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 28, 2025, 10:38 AM EDT - 10 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 17, 2025, 9:15 AM EDT - 10 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jul 9, 2025, 8:00 AM EDT - 11 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 30, 2025, 9:21 AM EDT - 11 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Jun 3, 2025, 9:15 AM EDT - 1 year ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 3:12 PM EDT - 1 year ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 1 year ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 14, 2025, 9:15 AM EDT - 1 year ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

May 13, 2025, 9:15 AM EDT - 1 year ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 22, 2025, 9:20 AM EDT - 1 year ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 9, 2025, 9:25 AM EDT - 1 year ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Apr 4, 2025, 9:40 AM EDT - 1 year ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 1 year ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 1:25 PM EST - 1 year ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Announces $15 million in Equity Committed

Feb 26, 2025, 9:15 AM EST - 1 year ago

Renovaro Announces $15 million in Equity Committed

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Jan 7, 2025, 6:51 PM EST - 1 year ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

AGPU

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Jan 6, 2025, 9:15 AM EST - 1 year ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 30, 2024, 9:00 AM EST - 1 year ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 23, 2024, 9:00 AM EST - 1 year ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 3:40 PM EST - 1 year ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

TCLutz
TCLutz May. 13 at 4:42 PM
$EZGO $HAO $KRKR $LNAI $POM Gamble…
0 · Reply
only1mc
only1mc May. 13 at 4:41 PM
$WOK 144 million traded. and climbing.. Im sure hedges don't want a lawsuit like $LNAI . .. no more shares left. 🚀 squeeze em
1 · Reply
MACnTEEZ
MACnTEEZ May. 13 at 3:43 PM
$LNAI gapper soon
0 · Reply
matthewboyntonbeach
matthewboyntonbeach May. 13 at 2:35 PM
$LNAI Blackrock owns 127,314 shares, if they start loading up more shares we going wayyyyy higher
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 13 at 1:19 PM
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research $OTLC $AMGN $JNJ $ABBV $LNAI https://ibn.fm/v9RPJ
0 · Reply
matthewboyntonbeach
matthewboyntonbeach May. 13 at 3:19 AM
$LNAI do something stupid tomorrow please, like open above $1.50
1 · Reply
MACnTEEZ
MACnTEEZ May. 12 at 11:58 PM
$LNAI people didnt digest or see the news, this will gap soon, ill give it few days!
0 · Reply
TCLutz
TCLutz May. 12 at 9:05 PM
$HAO <— $AIXI $LNAI $NVDA $SPY THE QUEEN HAS SPOKEN!! 🫡💪
0 · Reply
TCLutz
TCLutz May. 12 at 9:00 PM
$HAO <— $AIXI $LNAI $NVDA $SPY LOWEST PRICED + EXTREMELY OVERSOLD AI PLAY ON THE ENTIRE MARKET Offering closes today. Raised a measly $6.5m… Should rebound HARD to .25 or better!! 💪🫡🔥
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 12 at 7:21 PM
InvestorNewsBreaks – $LNAI Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit https://ibn.fm/xlRH8
0 · Reply
JuanValdex
JuanValdex May. 12 at 1:14 PM
$LNAI $BFRG ,, WE KNEW THIS HAPPENED J-6.. WHERE WERE YA CORE IR? but seriously you pussies ... maybe we the market will realize there is more space for him at the lunai board and he can do a stock swap 2/1 by selling bfrg and buying lunai . it seems like a good tax move FOR HIM.
0 · Reply
Porto98
Porto98 May. 12 at 1:14 PM
$LNAI
0 · Reply
only1mc
only1mc May. 12 at 12:46 PM
$CREG unnatural naked shorting right there. they are not good enough to win without that card in their back pocket. $LNAI is taking them to court. i hope its way more then a slap on the wrist. sec allows it. Crazy game we play. with an imaginary ball
2 · Reply
Kevkm1989
Kevkm1989 May. 12 at 11:24 AM
$LNAI not only are shorts screwed they are going to jail https://www.globenewswire.com/news-release/2026/05/12/3292467/0/en/dickinson-wright-and-fox-rothschild-join-forces-to-file-lawsuit-against-john-doe-naked-short-sellers-of-lunai-common-stock.html
3 · Reply
DC351988
DC351988 May. 12 at 10:48 AM
$LNAI Lunai Bioworks Files Delaware Federal Lawsuit Against Naked Short-Sellers Who Traded ~554M Shares On March 17, 2026, Representing 15.3 Times Company's Total Outstanding Shares 05/12/26 2:08 AM
0 · Reply
TCLutz
TCLutz May. 12 at 12:32 AM
$HAO Overnight always gives me false hope… Do it for us one time! Lol Let’s see a recovery to ~.15 😈 $POM $LNAI $KRKR $EZGO
0 · Reply
Stengaard1
Stengaard1 May. 11 at 9:56 PM
$LNAI $LNAI at the stockholder meeting on May the 8th the shareholders gave the board permission to make a reverse split in order to regain compliance with the 1 dollar rule - the jury is still out as to whether or not this will satisfy Nasdaq https://ir.lunaibioworks.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=19432192
1 · Reply
TCLutz
TCLutz May. 11 at 8:09 PM
$HAO Directions not clear… slammed fingers in door… barely missed my nutsack on that one! 🤣 $KRKR $POM $EZGO $LNAI
1 · Reply
Lizandro
Lizandro May. 11 at 6:07 PM
$LNAI grave yard here 😓😓😨
0 · Reply
TCLutz
TCLutz May. 11 at 2:06 PM
$EZGO 9658% borrow fee!? $AIXI $AKAN $SPY $LNAI
0 · Reply
matthewboyntonbeach
matthewboyntonbeach May. 11 at 12:53 PM
$LNAI no where to go up, $1, $10, $100
0 · Reply
sidhero
sidhero May. 11 at 11:06 AM
$LNAI news?
2 · Reply